Compounds for targeted immunotherapy compositions comprising the compounds and use of the compounds in the treatment of diseases such as cancer are disclosed. The compounds having the structure of formula TM Ln AM wherein TM is a targeting moiety AM is an activating moiety that is capable of activating a human dendritic cell NK cell or tumor cell or a combination thereof Ln is a linker and n is an integer selected from 0 and 1.
